AM Biotech Becomes Taiwan’s First Halal-Certified Exosome Company, Leveraging Proprietary Bio-Pulsed Technology to Tap into the US$100 Billion Global Halal Beauty Market

Source from: 經濟日報

AM Biotech, a Taiwan-based biotechnology innovator specializing in exosome technology, announced on March 2 that its proprietary exosome-based cosmetic ingredient has officially obtained Halal Certification, making the company the first exosome technology provider in Taiwan to achieve this milestone.

Dr. Ju-Sheng Hsieh, Chairman of AM Biotech, stated that the certification represents a significant step toward entering the global Muslim consumer market, which accounts for more than one-quarter of the world’s population. With the global halal beauty industry projected to exceed US$100 billion annually, this achievement marks an important milestone in AM Biotech’s international expansion strategy.

According to market research firm Fortune Business Insights, the global halal cosmetics market is projected to grow from US$47.76 billion in 2024 to US$115.03 billion by 2032, with the Asia-Pacific region emerging as a key growth market. Driven by a younger Muslim population and increasing purchasing power, demand for premium aesthetic treatments and high-performance skincare products continues to rise.

Dr. Hsieh emphasized that obtaining Halal Certification will accelerate AM Biotech’s expansion into Southeast Asia, the Middle East, and South Asia, further strengthening the company’s strategic position in the global exosome industry.

The term “Halal,” derived from Arabic, means “permissible” or “lawful” under Islamic principles. Halal Certification verifies compliance with specific Islamic requirements governing ingredients, manufacturing processes, and quality standards across industries, including food, pharmaceuticals, and cosmetics.

With extensive expertise in biopharmaceuticals and regenerative medicine, AM Biotech has continuously invested in the research, optimization, and innovative applications of exosome technology. Successfully obtaining Halal Certification for its exosome-based cosmetic ingredient demonstrates the company’s commitment to meeting stringent requirements throughout the entire production process—from raw material selection and manufacturing procedures to quality control and traceability.

Proprietary Bio-Pulsed Technology: Advancing the Next Generation of Functional Exosomes

At the core of AM Biotech’s competitive advantage is its proprietary Bio-Pulsed Induction Technology, supported by patent protection across 22 countries and multiple research publications in international peer-reviewed scientific journals.

Through continuous technological innovation, AM Biotech has developed three major breakthroughs in exosome technology:

1. Room-Temperature Stability for Liquid Exosome Formulations

AM Biotech has developed liquid exosome formulations capable of maintaining stability at room temperature, addressing the limitations of conventional biological materials that require cold-chain transportation and storage.

This advancement reduces logistical complexity and improves accessibility for clinical research, cosmetic formulation development, and commercial applications, supporting the broader adoption of exosome technology in international markets.

2. High-Purity Exosome Technology Achieving 99.99% Purity

AM Biotech’s proprietary exosome platform achieves a reported purity level of 99.99%, reflecting its advanced purification capabilities and stringent quality control standards.

High-purity manufacturing is a key component of the company’s approach to ingredient quality, safety, and consistency, providing a reliable foundation for developing high-performance exosome-based products.

3. Function-Oriented Exosome Engineering Through Bio-Pulsed Induction

Unlike conventional exosome production methods, AM Biotech’s proprietary Bio-Pulsed Technology enables targeted modulation of cellular gene expression to produce exosomes with specific functional characteristics.

By precisely regulating cellular conditions through biochemical stimulation, the platform is designed to enhance targeted biological activities for different applications.

To date, AM Biotech has developed more than 30 types of function-oriented exosomes, with research indicating several-fold to tens-fold improvements in selected functional activities compared with conventional exosomes under evaluated experimental conditions.

This technology provides a versatile platform for advancing exosome applications across regenerative medicine, aesthetic science, skincare, and scalp and hair care.

Halal Certification Strengthens Global Partnerships and Market Expansion

Dr. Hsieh stated that achieving Halal Certification represents more than a regulatory milestone. It reflects AM Biotech’s long-term commitment to providing consumers worldwide with scientifically validated, high-quality cosmetic solutions that respect diverse cultural and religious requirements.

The company will continue to advance exosome applications in skincare, scalp care, and hair care, bringing biotechnology innovations to global markets while upholding rigorous quality and ethical manufacturing standards.

AM Biotech also welcomes collaboration with international cosmetic brands, distributors, ingredient partners, and OEM/ODM manufacturers seeking to develop innovative exosome-based products and expand into emerging markets.

Through its proprietary technology platform, regulatory achievements, and international partnership network, AM Biotech aims to create new opportunities for the global beauty and biotechnology industries.

Advancing Exosome Innovation from Taiwan to the Global Market

Looking ahead, AM Biotech will continue strengthening its international presence by integrating its global patent portfolio, standardized manufacturing processes, and strategic market development initiatives.

As worldwide demand grows for clean ingredients, ethically responsible manufacturing, and scientifically substantiated product performance, AM Biotech remains committed to driving innovation through advanced biotechnology and uncompromising quality standards.

By bridging scientific research with scalable commercial applications, the company aims to accelerate the global adoption of exosome technology, enhance its technological and industrial impact, and establish itself as a world-class leader in regenerative medicine and functional skincare innovation.